Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 6.92 | 7.27 | 0.35 |
Stocks | 90.40 | 90.40 | 0.00 |
Convertible | 0.23 | 0.23 | 0.00 |
Preferred | 2.03 | 2.03 | 0.00 |
Other | 0.42 | 0.42 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 26.66 | 20.52 |
Price to Book | 4.52 | 4.45 |
Price to Sales | 4.76 | 2.44 |
Price to Cash Flow | 16.32 | 17.32 |
Dividend Yield | - | 1.11 |
5 Years Earnings Growth | 26.74 | 11.01 |
Number of long holdings: 90
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Zentalis Pharmaceuticals Inc Ordinary Shares | - | 6.03 | - | - | |
Celldex Therapeutics Inc | - | 3.81 | - | - | |
Shockwave Medical Inc | - | 3.76 | - | - | |
Inari Medical Inc Ordinary Shares | - | 3.14 | - | - | |
Lexeo Therapeutics Inc | - | 3.07 | - | - | |
Collegium Pharmaceutical Inc | - | 2.90 | - | - | |
Crinetics Pharmaceuticals Inc | - | 2.88 | - | - | |
Korro Bio Inc | - | 2.81 | - | - | |
Aura Biosciences Inc | - | 2.65 | - | - | |
Keros Therapeutics Inc | - | 2.62 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Eventide Gilead I | 2.43B | -6.07 | -6.37 | 9.96 | ||
Eventide Healthcare & Life ScienceI | 1.16B | -7.65 | -6.64 | 11.09 | ||
Eventide Gilead N | 425.08M | -6.15 | -6.56 | 9.74 | ||
Eventide Gilead A | 321.97M | -6.16 | -6.60 | 9.69 | ||
Eventide Gilead C | 166.38M | -6.46 | -7.31 | 8.87 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review